Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder

Psychiatric Services

Volumn 59, Issue 7, 2008, Pages 753-759

  Sajatovic, Martha ^a   Biswas, Kousick ^b   Kilbourne, Amy K ^c   Fenn, Howard ^d   Williford, William ^f   Bauer, Marks S ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d STANFORD UNIVERSITY   (United States)

^e VA BOSTON HEALTHCARE SYSTEM   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSOCIATION; BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SUICIDE ATTEMPT; TELEPHONE; VETERAN;

EID: 49949099061     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2008.59.7.753     Document Type: Article

References (52)

1. Murray CJ, Lopez AD: Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study. Lancet 349:1436-1442, 1997
2. Colom F, Vieta E, Tacci MJ, et al: Identifying and improving non-adherence in bipolar disorder. Bipolar Disorders 7:24-31, 2005
3. Lingam R, Scott J: Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica 105:164-172, 2002
4. Begley CE, Annegers JF, Swann AC, et al: The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 19:483-495, 2001
5. Colom F, Vieta E, Martinez-Aran A, et al: Clinical factors associated with treatment noncompliance in euthymic bipolar patients. Journal of Clinical Psychiatry 61: 549-555, 2000
6. Connelly CE: Compliance with outpatient lithium therapy. Perspectives in Psychiatric Care 22:44-50, 1984
7. Keck PE Jr, McElroy SL, Strakowski SM, et al: Compliance with maintenance treatment in bipolar disorder. Psychopharmacological Bulletin 33:87-91, 1997
8. Licht RW, Vestergaard P, Rasmussen NA, et al: A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients. Acta Psychiatrica Scandinavica 104:387-390, 2001
9. Perlick DA: Medication non-adherence in bipolar disorder: a patient-centered review of research findings. Clinical Approaches in Bipolar Disorders 3:56-64, 2004
10. Aagaard J, Vestergaard P: Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. Journal of Affective Disorders 18:259-266, 1990
11. Aagaard J, Vestergaard P, Maarbjerg K: Adherence to lithium prophylaxis: II. multivariate analysis of clinical, social, and psychosocial predictors of nonadherence. Pharmacopsychiatry 21:166-170, 1988
12. Coldham EL, Addington J, Addington D: Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica 106:286-290, 2002
13. Colom F, Vieta E: Treatment adherence in bipolar patients. Clinical Approaches in Bipolar Disorders 1:49-56, 2002
14. Maarbjerg K, Aagaard J, Vestergaard P: Adherence to lithium prophylaxis: I. clinical predictors and patient's reasons for nonadherence. Pharmacopsychiatry 21:121-125, 1988
15. Miklowitz DJ: Longitudinal outcome and medication noncompliance among manic patients with and without mood-incongruent psychotic features. Journal of Nervous and Mental Disease 180:70:3-711, 1992
16. Janz NK, Becker MH: The health beliefs mode: a decade later. Health Education Quarterly 11:1-47, 1984
17. Kelly GR: Utility of the health belief model in examining medication compliance among psychiatric outpatients. Social Science of Medicine 25:1205, 1987
18. Osterberg L, Blaschke T: Adherence to medication. New England Journal of Medicine 353:487-497, 2005
19. Scott J, Pope M: Nonadherence with mood stabilizers: prevalence and predictors. Journal of Clinical Psychiatry 63:384-390, 2002
20. Sajatovic M, Bauer MS, Kilbourne AM, et al: Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatric Services 57:56-62, 2006
21. Valenstein M, Ganoczy D, McCarthy JF, et al: Antipsychotic adherence over time among patients receiving treatment for schizophrenia. Journal of Clinical Psychiatry 67:1542-1550, 2006
22. Gonzales-Pinto A, Mosquera F, Alonso M, et al: Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disorders 8:618-624, 2006
23. Weiss KA, Smith TE, Hull JW, et al: Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders. Schizophrenia Bulletin 28:341-349, 2002
24. Bauer MS, McBride L, Williford WO, et al: Collaborative care for bipolar disorder: part I. intervention and implementation in a randomized effectiveness trial. Psychiatric Services 57:927-936, 2006
25. Bauer MS, McBride L, Williford WO, et al: Collaborative care for bipolar disorder: part II. impact on clinical outcome, function and costs. Psychiatric Services 57:937-945, 2006
26. Bauer MS, Williford W, Dawson E, et al: Principles of effectiveness trials and their implementation in VA Cooperative Study #430, "reducing the efficacy-effectiveness gap in bipolar disorder." Journal of Affective Disorders 67:61-78, 2001
27. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
28. Folstein M, Folstein S, McHugh P: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research 12: 189-198, 1975
29. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for Axis I DSM-IV Disorders - (SCID) Patient Edition, version 2.0. New York, New York Psychiatric Institute, Biometrics Research Department, 1996
30. Nabati L, Shea N, McBride L, et al: Adaptation of a simple patient satisfaction survey in mental health: psychometric properties. Psychiatry Research 77:51-56, 1998
31. Stewart A, Hays R, Ware J: The MOS short-form general health survey: reliability and validity in a patient population. Medical Care 26:724-735, 1988
32. Keller M, Lavori P, Klerman GL, et al: Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Archives of General Psychiatry 43:458-466, 1986
33. Glaser W, Aaronson H, Prussof B, et al: Assessment of social adjustment in chronic ambulatory schizophrenics. Journal of Nervous and Mental Disease 168:493-497, 1980
34. Fenn HH, Bauer MS, Altshuler L, et al: Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. Journal of Affective Disorders 86:47-60, 2005
35. Horvath AO, Greenberg LS: Development and validation of the Working Alliance Inventory. Journal of Consulting and Clinical Psychology 36:223-233, 1989
36. Bauer M, Williford W, McBride L, et al: Perceived barriers to health care access in a treated population. International Journal of Psychiatry in Medicine 35:13-26, 2005
37. Bauer MS, Altshuler L, Evans DR, et al: Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. Journal of Affective Disorders 85:301-315, 2005
38. Brown GR, McBride L, Bauer MS, et al: Impact of childhood abuse on bipolar disorder. Journal of Affective Disorders 89:57-67, 2005
39. Sajatovic M, Shelton MD, Elhaj O, et al: Treatment adherence in patients with rapid cycling bipolar disorder: results from a clinical trials setting. Journal of Clinical Psychopharmacology, in press
40. Calabrese JR, Suppes T, Bowden CL, et al: A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder: Lamictal 614 Study Group. Journal of Clinical Psychiatry 61:841-850, 2000
41. Calabrese JR, Shelton MD, Rapport DJ, et al: A 20-month, double-blind, maintenance trial of lithium vs divalproex in rapid-cycling bipolar disorder. American Journal of Psychiatry 162:2152-2161, 2005
42. Riedel M, Strassnig M, Muller N, et al: How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials? European Archives of Psychiatry and Clinical Neuroscience 255:143-148, 2005
43. Berk M., Berk, L, Castle D: A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disorders 6:504-518, 2004
44. Suppes T, Baldessarini RJ, Faedda GL, et al: Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry 48:1082-1088, 1991
45. Scott J: Predicting medication non-adherence in severe affective disorders. Acta Neuropsychiatrica 12:128-130, 2000
46. Muller-Oerlinghausen B, Muser-Causemann B, Volk J: Suicides and parasiticides in a high-risk patient group on and off lithium long-term medication. Journal of Affective Disorders 25:261-269, 1992
47. Schumann C, Lenz G, Berghofer A, et al: Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Research 89:247-257, 1999
48. Gonzales-Pinto A, Mosuera F, Alonso M, et al: Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disorders 8:618-621, 2006
49. Baldessarini RJ, Tondo L, Hennen J: Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. Journal of Clinical Psychiatry 60:77-84, 1999
50. McCarthy JF, Blow FC, Valenstein M, et al: Veterans Affairs Health System and mental health treatment retention among patients with serious mental illness: evaluating accessibility and availability barriers. Health Service Research 42:1042-1060, 2007
51. McCarthy JF, Piette JD, Fortney JC, et al: Outpatient Visit chaining among patients with serious mental illness. Medical Care 44:257-264, 2006
52. Stephenson BJ, Rowe BH, Haynes RB, et al: Is this patient taking the treatment as prescribed? JAMA 269:2779-2781, 1993